However, as reasoned for in our primary analysis of the ABCD2 score in our TIA cohort [7], patients with a low score also can have severe underlying pathology; hence, rapid evaluation in a specialized stroke center, either in an outpatient or inpatient setting, seems to be the essential factor for optimizing the outcome in all TIA patients. The gene discussed is ABCD2; the disease is Stroke.